News
Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced the Company has secured multiple market access ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback